153 related articles for article (PubMed ID: 25459668)
1. Angiogenic factors in chronic lymphocytic leukaemia (CLL): Where do we stand?
Aguirre Palma LM; Gehrke I; Kreuzer KA
Crit Rev Oncol Hematol; 2015 Mar; 93(3):225-36. PubMed ID: 25459668
[TBL] [Abstract][Full Text] [Related]
2. Angiogenic factors in chronic lymphocytic leukemia.
Xia Y; Lu RN; Li J
Leuk Res; 2012 Oct; 36(10):1211-7. PubMed ID: 22727510
[TBL] [Abstract][Full Text] [Related]
3. The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia.
Shanafelt TD; Kay NE
Semin Oncol; 2006 Apr; 33(2):174-85. PubMed ID: 16616064
[TBL] [Abstract][Full Text] [Related]
4. Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF.
Maffei R; Martinelli S; Castelli I; Santachiara R; Zucchini P; Fontana M; Fiorcari S; Bonacorsi G; Ilariucci F; Torelli G; Marasca R
Leuk Res; 2010 Mar; 34(3):312-21. PubMed ID: 19616847
[TBL] [Abstract][Full Text] [Related]
5. Role of angiogenesis in chronic lymphocytic leukemia.
Letilovic T; Vrhovac R; Verstovsek S; Jaksic B; Ferrajoli A
Cancer; 2006 Sep; 107(5):925-34. PubMed ID: 16832815
[TBL] [Abstract][Full Text] [Related]
6. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
[TBL] [Abstract][Full Text] [Related]
7. B-cell chronic lymphocytic leukemia: correlation of clinical stages with angiogenic cytokine expression.
Ho CL; Phyliky RL; Li CY
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):154-60. PubMed ID: 16785782
[TBL] [Abstract][Full Text] [Related]
8. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-9 induces a pro-angiogenic profile in chronic lymphocytic leukemia cells.
Aguilera-Montilla N; Bailón E; Ugarte-Berzal E; Uceda-Castro R; Prieto-Solano M; García-Martínez E; Samaniego R; Van den Steen PE; Opdenakker G; García-Marco JA; García-Pardo A
Biochem Biophys Res Commun; 2019 Nov; 520(1):198-204. PubMed ID: 31585732
[TBL] [Abstract][Full Text] [Related]
10. Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia.
Maffei R; Fiorcari S; Bulgarelli J; Rizzotto L; Martinelli S; Rigolin GM; Debbia G; Castelli I; Bonacorsi G; Santachiara R; Forconi F; Rossi D; Laurenti L; Palumbo GA; Vallisa D; Cuneo A; Gaidano G; Luppi M; Marasca R
Exp Hematol; 2014 Feb; 42(2):126-36.e1. PubMed ID: 24212063
[TBL] [Abstract][Full Text] [Related]
11. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.
Eggert A; Ikegaki N; Kwiatkowski J; Zhao H; Brodeur GM; Himelstein BP
Clin Cancer Res; 2000 May; 6(5):1900-8. PubMed ID: 10815914
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of syndecan-1 in B-cell chronic lymphocytic leukemia: correlation with the extent of angiogenesis and disease-progression risk in early disease.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Leuk Lymphoma; 2006 Jun; 47(6):1034-40. PubMed ID: 16840194
[TBL] [Abstract][Full Text] [Related]
13. Regulation of CLL survival by hypoxia-inducible factor and its target genes.
Shachar I; Cohen S; Marom A; Becker-Herman S
FEBS Lett; 2012 Aug; 586(18):2906-10. PubMed ID: 22841548
[TBL] [Abstract][Full Text] [Related]
14. Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia.
Kini AR; Kay NE; Peterson LC
Leukemia; 2000 Aug; 14(8):1414-8. PubMed ID: 10942237
[TBL] [Abstract][Full Text] [Related]
15. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.
Hüttmann A; Klein-Hitpass L; Thomale J; Deenen R; Carpinteiro A; Nückel H; Ebeling P; Führer A; Edelmann J; Sellmann L; Dührsen U; Dürig J
Leukemia; 2006 Oct; 20(10):1774-82. PubMed ID: 16932341
[TBL] [Abstract][Full Text] [Related]
16. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.
Bunone G; Vigneri P; Mariani L; Butó S; Collini P; Pilotti S; Pierotti MA; Bongarzone I
Am J Pathol; 1999 Dec; 155(6):1967-76. PubMed ID: 10595926
[TBL] [Abstract][Full Text] [Related]
17. Induction of endothelial cell proliferation and von Willebrand factor expression and secretion by leukemic plasma of patients with chronic lymphocytic leukemia before and after inhibition of NF-κB.
Shahidi M; Mohsen Razavi S; Hayat P
Blood Coagul Fibrinolysis; 2016 Sep; 27(6):711-6. PubMed ID: 27472040
[TBL] [Abstract][Full Text] [Related]
18. Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survival.
Shan S; Robson ND; Cao Y; Qiao T; Li CY; Kontos CD; Garcia-Blanco M; Dewhirst MW
FASEB J; 2004 Feb; 18(2):326-8. PubMed ID: 14688196
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
[TBL] [Abstract][Full Text] [Related]
20. Malignant hematopoietic cells induce an increased expression of VEGFR-1 and VEGFR-3 on bone marrow endothelial cells via AKT and mTOR signalling pathways.
Mirshahi P; Toprak SK; Faussat AM; Dubrulle S; Marie JP; Soria C; Soria J; Mirshahi M
Biochem Biophys Res Commun; 2006 Oct; 349(3):1003-10. PubMed ID: 16959214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
